drugset / Trial / NCT00000579

Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)

NCT00000579

FactorialTreatment

Summary

The purposes of this study are to assess rapidly innovative treatment methods in patients with adult respiratory distress syndrome (ARDS) as well as those at risk of developing ARDS and to create a network of interactive Critical Care Treatment Groups (CCTGs) to establish and maintain the required infrastructure to perform multiple therapeutic trials that may involve investigational drugs, approved agents not currently used for treatment of ARDS, or treatments currently used but whose efficacy has not been well documented.

Timeline

Start
1994-09
Primary completion
Completion
2004-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule
Subject Lisofylline Small molecule
Subject Methylprednisolone Other / unclassified